Search

everythinglearnresearchcommunity

for

Search:↓

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Procyanidin from Indonesian spices may help heal diabetic wounds.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Tofacitinib treatment is used for teenagers with alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Vitamin D may help reduce inflammation in acne.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

PCOS is linked to low-grade chronic inflammation.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

MC-1R is present in skin cells and may help reduce inflammation.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.